The potential effect of natural antioxidants on endothelial dysfunction associated with arterial hypertension

Rosamaria Caminiti1, Cristina Carresi2, Rocco Mollace1,3

  • 1Department of Health Sciences, Institute of Research for Food Safety and Health (IRC-FSH), University "Magna Graecia" of Catanzaro, Catanzaro, Italy.

PubMed

Insights

Natural antioxidants may help manage early arterial hypertension by protecting endothelial cells from oxidative damage. This review explores their role in preventing cardiovascular disease progression.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Natural Product Chemistry

Background:

  • Arterial hypertension is a major global cause of cardiovascular morbidity and mortality.
  • Effective early-stage blood pressure (BP) management remains crucial for cardiovascular risk prevention.
  • While antihypertensive drugs have advanced, the precise mechanisms disrupting BP regulation are not fully understood.

Purpose of the Study:

  • To review the role of oxidative stress in endothelial dysfunction contributing to arterial hypertension.
  • To evaluate the potential of natural antioxidants in managing hypertension and addressing unmet treatment needs.

Main Methods:

  • Literature review focusing on oxidative stress, endothelial dysfunction, and arterial hypertension.
  • Analysis of studies investigating natural antioxidants from plant extracts for antihypertensive effects.
  • Assessment of evidence regarding antioxidant mechanisms, particularly in endothelial cell protection.

Main Results:

  • Oxidative stress significantly contributes to endothelial dysfunction in early arterial hypertension.
  • Natural antioxidants show promise in counteracting oxidative damage to endothelial cells.
  • Plant-derived antioxidants may offer a viable strategy for managing hypertension.

Conclusions:

  • Natural antioxidants represent a potential therapeutic avenue for arterial hypertension.
  • Their ability to protect endothelial cells from oxidative stress is key to their efficacy.
  • Further research is warranted to fully elucidate their role in cardiovascular risk prevention.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
165
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
524
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
638
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
731
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
590